Effects of the onabotulinumtoxinA follow-up delay in migraine course during the COVID-19 lockdown.
Alicia Gonzalez-MartinezÁlvaro Planchuelo-GómezÁngel L GuerreroDavid Garcia AzorinSonia Santos-LasaosaMaría Pilar Navarro-PérezPaula Odriozola-GonzálezMaría Jesús IrurtiaSonia QuintasRodrigo de Luis-GarcíaAna Beatriz Gago-VeigaPublished in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2021)
Involuntary delay of onabotulinumtoxinA follow-up in patients with migraine due to COVID-19 pandemic was associated with a higher frequency of headache and migraine attacks. Safe administration of onabotulinumtoxinA during lockdown should be promoted.
Keyphrases